To examine different factors that are associated with initiation and discontinuation of methylphenidate use (incl. adherence). Furthermore, we have investigated the dispensation of age-related contraindicated medications to children, the risk of suicide in antidepressant users and we assessed the different sources that are used to determine the use of medication during pregnancy
Sherpa Romeo green journal. Permission to archive accepted author manuscriptThe prevalence of methy...
BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperacti...
BACKGROUND: Investigating drug utilization in large and unselected samples of children and adolescen...
Use of methylphenidate in children has increased substantially, despite conflicting evidence regardi...
Objectives: To determine methylphenidate use in children aged 2 to 13 years. To provide age- and sex...
Background: Pharmacoepidemiological studies on ADHD are limited in South Africa. The primary aim was...
MPharm (Pharmacy Practice), North-West University, Potchefstroom Campus, 2016This study set out to i...
Objectives: Numerous studies have examined determinants contributing to methylphenidate adherence an...
Objectives: To determine methylphenidate use in children aged 2 to 13 years. To provide age- and sex...
Background: There are concerns about the frequency and appropriateness of psychostimulant drug presc...
Introduction: Methylphenidate is the most frequently used medication for the treatment of attention-...
Objective: The aim of the study was to determine the changes in consumption of psychotropic drugs by...
Methylphenidate is primarily used for attention deficit hyperactivity disorder (ADHD) in children. T...
Background Studies on adolescent drug use are scarce as most studies do not distinguish between chil...
Multiple factors may contribute to the decision to initiate methylphenidate treatment in children su...
Sherpa Romeo green journal. Permission to archive accepted author manuscriptThe prevalence of methy...
BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperacti...
BACKGROUND: Investigating drug utilization in large and unselected samples of children and adolescen...
Use of methylphenidate in children has increased substantially, despite conflicting evidence regardi...
Objectives: To determine methylphenidate use in children aged 2 to 13 years. To provide age- and sex...
Background: Pharmacoepidemiological studies on ADHD are limited in South Africa. The primary aim was...
MPharm (Pharmacy Practice), North-West University, Potchefstroom Campus, 2016This study set out to i...
Objectives: Numerous studies have examined determinants contributing to methylphenidate adherence an...
Objectives: To determine methylphenidate use in children aged 2 to 13 years. To provide age- and sex...
Background: There are concerns about the frequency and appropriateness of psychostimulant drug presc...
Introduction: Methylphenidate is the most frequently used medication for the treatment of attention-...
Objective: The aim of the study was to determine the changes in consumption of psychotropic drugs by...
Methylphenidate is primarily used for attention deficit hyperactivity disorder (ADHD) in children. T...
Background Studies on adolescent drug use are scarce as most studies do not distinguish between chil...
Multiple factors may contribute to the decision to initiate methylphenidate treatment in children su...
Sherpa Romeo green journal. Permission to archive accepted author manuscriptThe prevalence of methy...
BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperacti...
BACKGROUND: Investigating drug utilization in large and unselected samples of children and adolescen...